Analysis of a SHA-256 Variant

Hirotaka Yoshida,A. Biryukov

DOI: https://doi.org/10.1007/11693383_17

2005-08-11

Abstract:

What problem does this paper attempt to address?

Epithelioid hemangioendothelioma of the parotid gland: A case report in an unusual location with a review of the literature

David A Suarez-Zamora,Paula A Rodriguez-Urrego,Jose A Hakim-Tawil,Mauricio A Palau-Lazaro

DOI: https://doi.org/10.1016/j.patol.2019.04.002

Abstract:Epithelioid hemangioendothelioma (EHE) is a malignant vascular tumor that usually affects the liver, lung, bone and deep soft tissues of the extremities or trunk. To our knowledge, only 3 cases in the parotid gland have been reported to date. We report a case of a 62-year-old woman who presented with a 1-year history of a slow-growing, painless mass over the left mandibular angle. Imaging studies showed a 2cm mass over the left parotid gland with peripheral calcifications. The patient underwent a superficial parotidectomy. Sections displayed neoplastic epithelioid cells with cytoplasmic vacuoles containing erythrocytes, surrounded by a myxohyaline stroma. Immunohistochemistry was positive for CD31, CD34, ERG, and factor VIII, but negative for cytokeratin AE1/AE3, CK7, EMA, SMA, and S100. The findings were those of an EHE involving the parotid gland. This case demonstrates an EHE in a rare location and emphasizes the need to consider this tumor when diagnosing uncommon soft tissue tumors of salivary glands.
Epithelioid Hemangioendothelioma as a Dangerous, Easy to Miss, and Nearly Impossible to Clinically Diagnose Condition: Case Report

Kayd Pulsipher,Samantha Mills,Blair Harris,Rene Bermudez,Muammar Arida,Jonathan Crane

DOI: https://doi.org/10.2196/52493

2024-08-28

Abstract:Epithelioid hemangioendothelioma (EHE) is a rare vascular tumor with metastatic potential. EHE can have single- or multiorgan involvement, with presentations ranging from asymptomatic disease to pain and systemic symptoms. The extremely heterogeneous clinical presentation and disease progression complicates EHE diagnosis and management. We present the case of a 24-year-old woman with two periauricular erythematous papules, leading to the discovery of metastatic EHE through routine biopsy, despite a noncontributory medical history. Histology revealed the dermal proliferation of epithelioid cells and vacuoles containing red blood cells. Immunohistochemistry markers consistent with EHE solidified the diagnosis. Although extremely rare, prompt diagnosis of EHE is essential for informed decision-making and favorable outcomes. Key clinical and histopathological findings are highlighted to aid dermatologists in diagnosing and managing this uncommon condition.
Primary Intranodal Epithelioid Haemangioendothelioma in the Submandibular Region: A Case Report

Khilan Shukla,Touraj Taheri,Hooman Baghaie,Omar Breik

DOI: https://doi.org/10.1007/s12070-024-04752-2

Abstract:Epithelioid haemangioendothelioma (EHE) is a rare vascular tumour that primarily affects the liver, lungs and bone. It is very rarely described in the head and neck region, and is exceptionally uncommon within the submandibular region. We report a very rare case of EHE originating in a lymph node within the submandibular salivary gland of a 54-year-old female patient. The tumour was resected and the patient was regularly followed up, with no recurrence of disease at 24 months postoperatively. A review of existing literature, clinical and immunohistopathological features are discussed, which highlight the diagnostic dilemma, absence of consensus for management and appropriate surveillance method associated with EHE.
A case report of parotid gland epithelioid hemangioendothelioma

Ke Wang,Jianhong Hu,Jiazhu Wen,Shuxia Zhou,Linfeng Ye,Chun Fang,Jiacheng Guan,Xiao Luo

DOI: https://doi.org/10.3389/fsurg.2024.1367059

IF: 1.8

2024-04-22

Frontiers in Surgery

Abstract:Epithelioid hemangioendothelioma (EHE) is a rare low-grade malignant vascular tumor. It mainly occurs in the liver, lungs, bones, and other parts of the body. Reports of epithelioid hemangioendothelioma in the parotid gland are rare in both domestic and international literature. Here, we present a case report of a parotid gland epithelioid hemangioendothelioma, including its complete clinical course and imaging findings, to improve the diagnosis and treatment of this unusual disease. Case presentation The patient, a 75-year-old female, presented with a swelling around the right ear for 2 months and pain for 20 days. Enhanced MRI of the parotid gland revealed a well-defined, round mass with homogeneous signal intensity. The mass showed low signal intensity on T1-weighted imaging, high signal intensity on T2-weighted imaging, nodular low signal intensity within, significant high signal intensity on DWI sequence, low signal intensity on ADC sequence, and heterogeneous enhancement in the arterial phase after intravenous injection of Gd-DTPA. Nodular non-enhancing low signal intensity was observed internally, and slight clearance was seen in the venous phase. The initial diagnosis before surgery was a benign lesion, but after histopathological and immunohistochemical examination, it was confirmed as epithelioid hemangioendothelioma. Intervention Complete tumor resection was performed. Results The patient experienced a favorable recovery, with meticulous follow-up conducted for up to 1 year revealing no signs of recurrence or metastasis. Continued patient surveillance is ongoing to substantiate and validate the long-term efficacy of the treatment. Conclusion Due to the extreme rarity of parotid gland epithelioid hemangioendothelioma, it often leads to a high misdiagnosis rate. The most common misdiagnosis is salivary gland lymphoma, followed by epithelioid hemangiosarcoma. When the lesion is multifocal, fusiform, with internal necrosis, and shows punctate low signal intensity on T2-weighted imaging, significant enhancement in the arterial phase, particularly with more pronounced peripheral enhancement, and persistent enhancement in the venous and delayed phases, epithelioid hemangioendothelioma should be considered. However, the current clinical diagnosis of epithelioid hemangioendothelioma still primarily relies on immunohistochemical methods.

surgery
An extremely rare case of pulmonary epithelioid hemangioendothelioma

Xi Chen,Yun Wang,Guowei Che,Cheng Shen

DOI: https://doi.org/10.1111/1759-7714.15051

IF: 3.223

2023-07-26

Thoracic Cancer

Abstract:Histological features of EHE: Hematoxylin and eosin (H&E) indicated that the tumor tissue morphology is diverse, showing nodular growth, showing well‐defined eosinophilic nodules, and transparent degeneration or coagulative necrosis similar to amyloidosis or chondroma can be seen in the center. There are many cells around the nodule, and the cell mass located in the mucilaginous chondroid matrix extends into the alveolar cavity, bronchioles, blood vessels, and lymphatic vessel. Part of the alveoli are filled with patches of tumor cells, presenting as papillary or glomerular like hyperplasia, with obvious hyaline degeneration in the interstitium, and relatively normal alveolar septa. Tumor cells have prominent epithelioid features, similar to epithelial cells, tissue cells, or decidual cells, arranged in a nest, cord, or irregular shape. CK7 and TFE‐3 staining was negative. CAMTA‐1, CD34, and CD31 were also positive. (a: CK7, b: TFE‐3, c: CAMTA‐1, d: CD34, e: CD31, f: Hematoxylin and eosin). Epithelioid emangioendothelioma (EHE) is a rare tumor originating from vascular endothelial cells, which belongs to malignant vascular tumors with low to moderate differentiation and potential metastatic ability and its incidence rate is less than one in a million. We herein report a rare case of EHE of pulmonary origin and a review of the literature concerning the clinical and pathological features of this disease. The patient underwent left upper lobectomy to completely extirpate the lesion by video‐assisted thoracic surgery. Our findings suggest the difficulty of making a diagnosis before surgery and that more cases need to be reported in order to facilitate the preoperative diagnosis of such a rare tumor.

oncology,respiratory system
Primary Malignant Myoepithelioma of the Left Maxillary Sinus: a Case Report.

S. H. Zhou,L. X. Ruan,L. Gong,S. Q. Wang

DOI: https://doi.org/10.1177/147323000803600221

2008-01-01

Abstract:We describe the case of a 41-year-old woman who presented with a malignant myoepithelioma (MME) in her left maxillary sinus. Exploratory biopsy of the left maxillary sinus was performed and pathological examination demonstrated that the tumour was positive for calponin and cytokeratin 14, which are indicative of MME. Lateral rhinotomy and left total maxillectomy were undertaken and the patient received radiotherapy and chemotherapy post-surgery. Primary recurrence and metastasis to the left angle of the mandible occurred 9 months after the surgery. The patient died of cachexia 13 months after the surgery.
Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment

Ari Rosenberg,Mark Agulnik

DOI: https://doi.org/10.1007/s11864-018-0536-y

2018-03-15

Current Treatment Options in Oncology

Abstract:Opinion statementEpithelioid hemangioendothelioma (EHE) is an extremely rare sarcoma, as such it can pose a clinical dilemma based solely on its rarity. Also, the spectrum of disease varies greatly between an indolent disease and aggressive disease with widespread metastases. In our clinical practice, the primary focus has been to get a handle on the aggressive nature of the disease, which will then dictate how urgently one needs to treat the patient. Pathological review with immunohistochemistry and molecular characterization is paramount. Our treatment strategy is watch-and-wait versus active therapy on clinical trial or based on results of prior clinical trials. There is evidence to support the use of chemotherapeutics and targeted therapies specifically focusing on anti-angiogenesis. The current landscape of oncology with the emergence and excitement of immunotherapy could also translate in a role for immunotherapy in this disease. While rare, there is certainly no reason that research and trials for patients with EHE should not remain on utmost importance for those of us who specialize in the treatment of sarcomas.

oncology
Rapidly Progressive and Debilitating Epithelioid Hemangioendothelioma: An Atypical Presentation of a Rare Malignant Cutaneous Vascular Neoplasm

Siddhartha Dash,Biswanath Behera,Parvathy Viswan,Kunal Garg,Madhusmita Sethy,Pavithra Ayyanar

DOI: https://doi.org/10.1097/dad.0000000000002625

2024-03-16

American Journal of Dermatopathology

Abstract:Epithelioid hemangioendothelioma (EHE) is a rare vascular malignant tumor that comprises less than 1% of all vascular tumors. Cutaneous involvement in EHE can occur either by spreading from underlying bone or rarely could be limited to the skin and mostly presents as solitary well-circumscribed mass to an ill-defined infiltrative lesion. We present a case of rapidly progressive and debilitating EHE presenting multiple vascular papules and nodules. Histopathology showed an ill-circumscribed nodular proliferation of epithelioid and spindled cells in the dermis that extended into the subcutaneous tissue. The tumor cells had moderate eosinophilic cytoplasm, vesicular chromatin, and prominent nucleoli. In addition, they showed evidence of lumen formation and intracytoplasmic vacuoles. Brisk mitosis was noted. On immunohistochemistry, the cells were strongly positive for CD31, CD34, and ERG (ETS [erythroblast transformation-specific]-related gene). MIB-1 labeling index was more than 75% in the highest proliferating areas. A high degree of clinical suspicion and immunopathological examination is recommended for early diagnosis of this rare condition before it becomes function or life-threatening.

dermatology
Vulvar epithelioid hemangioendothelioma

Benedito Borges da Silva,Pedro Vitor Lopes-Costa,Ana Maria Furtado-Veloso,Rafael Soares Borges

DOI: https://doi.org/10.1016/j.ygyno.2007.01.022

Abstract:Background: Epithelioid hemangioendothelioma (EH) is a rare vascular tumor whose localization in the vulva is extremely rare. Case: The present case report refers to a 19-year-old Brazilian woman admitted to hospital with an extensive lesion of granulomatous appearance on the right labium majus. Following confirmation of the diagnosis of epithelioid hemangioendothelioma, the only treatment consisted of hemivulvectomy and right inguinal lymphadenectomy. Patient was lost to follow-up for 8 years after recovery from surgery. She reappeared 4 years ago and is now being followed-up. There is no sign of recurrence of the disease. Conclusion: EH is a lesion of unpredictable malignancy whose localization in the vulva is extremely rare. The first therapeutic option is surgical resection.
Diaphragm epithelioid hemangioendothelioma: a rare case report

Qin Yan,Shuai Li,Li Zhang,Sishi Tang,Nianyong Chen,Lang He

DOI: https://doi.org/10.1186/s12877-024-05536-7

IF: 4.07

2024-11-23

BMC Geriatrics

Abstract:Epithelioid Hemangioendothelioma (EHE) is an extremely rare malignancy originating from endothelial cells, with an incidence rate of less than 1/100,000. To date, there have been no documented cases of Diaphragm EHE in the English or Chinese literature. EHE can manifest in various organs throughout the body and lacks distinctive clinical features, often leading to misdiagnosis. Given its rarity, there is currently no standardized treatment protocol, management options include radiotherapy, chemotherapy, and targeted therapy. In this report, we present a case study of a 75-year-old male patient who presented with a 6-month history of cough, sputum production, chest tightness, and pleural effusion. A biopsy of the diaphragm mass and immunohistochemical analysis of the pleural fluid confirmed the diagnosis of EHE. The patient underwent chemotherapy combined with targeted therapy, however, unfortunately experienced disease progression.

geriatrics & gerontology,gerontology
Imaging findings in epithelioid hemangioendothelioma

Yan Epelboym,Dawn R Engelkemier,Frederic Thomas-Chausse,Ahmad I Alomari,Alyaa Al-Ibraheemi,Cameron C Trenor,Denise M Adams,Gulraiz Chaudry,Ahmad I. Alomari,Cameron C. Trenor,Denise M. Adams

DOI: https://doi.org/10.1016/j.clinimag.2019.06.002

IF: 2.42

2019-11-01

Clinical Imaging

Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Purpose-objective</h3><p>Epithelioid hemangioendothelioma (EHE) is a rare vascular malignancy with varying biologic behavior. The purpose of this study was to identify imaging findings most characteristic of EHE.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>Retrospective review of clinical and imaging records in patients referred to our Vascular Anomalies Center over a 17 year period with biopsy proven EHE.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>We evaluated 29 patients (17 F) with median age of 16 years (range 2–76 y). The most common presenting symptoms were pain (n = 13) and palpable mass (n = 7). 22 (70%) had multifocal disease. Most common sites of involvement were lung (n = 25), liver (n = 16), bone (n = 12), soft tissue (n = 3) and lymph nodes (n = 1). Of patients with single site disease, 3 had lung, 3 liver, and 1 had bone lesions. In 18/25 with lung disease, there were multiple nodules of varying sizes and characteristics. In 14/16 with hepatic disease there were multiple nodules with predominantly peripheral distribution. Subcapsular retraction was seen in 10/16 and a "lollipop" sign (hepatic or portal vein tapering at the edge of a well-defined hypoenhancing lesion) identified in 5/16. Of 12 osseous lesions, 11 were lytic, 8 involved vertebrae and 9 involved the axial skeleton.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>EHE has varied imaging findings. The most common sites are lungs, liver, and bone, with multi-organ involvement seen in most. Lung disease is most commonly characterized by multiple nodules. Hepatic lesions demonstrate the most distinctive findings, with peripheral distribution, lack of early enhancement, subcapsular retraction and "lollipop" sign. Osseous lesions are commonly lytic and more prevalent in the axial skeleton.</p>

radiology, nuclear medicine & medical imaging
Epithelioid hemangioendothelioma: an overview and update on a rare vascular tumor

Angela Sardaro,Lilia Bardoscia,Maria Fonte Petruzzelli,Maurizio Portaluri

DOI: https://doi.org/10.4081/oncol.2014.259

2014-10-13

Oncology Reviews

Abstract:Epithelioid hemangioendothelioma is a rare vascular tumor, described for the first time in 1975 by Dail and Liebow as an aggressive bronchoalveolar cell carcinoma. The etiology is still a dilemma. Studies about suggestive hypothesis are ongoing. Most of the times it affects lung, liver and bones, although this kind of tumor may involve the head and neck area, breast, lymph nodes, mediastinum, brain and meninges, the spine, skin, abdomen and many other sites. Because of its heterogeneous presentation, as it represents less than 1% of all the vascular tumors, it is often misdiagnosed and not suitably treated, leading to a poor prognosis in some cases. Over 50-76% of the patients are asymptomatic. A small number of them complains respiratory symptoms. Bone metastases might cause pathological fractures or spine compression, if they arise in vertebrae. Imaging is necessary to determine morphological data, the involvement of surrounding tissues, and potentially the cleavage plan. It is important to recognize the expression of vascular markers (Fli-1 and CD31 are endothelial-specific markers), and the microscopic evidence of vascular differentiation to make a correct diagnosis, as many pulmonary diseases show multiple nodular lesions. Because of its rarity, there is no standard for treatment. We focused on radiotherapy as a good therapeutic option: despite the poor prognosis, evidence is in favor of radiotherapy which offers local pain control with good tolerance and better quality of life at least at a one-year follow-up in most of cases. Further studies are needed to establish the standard radiation dose to be used for locoregional control of such a complex and extremely rare disease.
Epithelioid Hemangioendothelioma of Bone: a Study of 4 Cases and Review of Literature

ZHOU Jun,YIN Hong-lin,ZHANG Hai-fang,MA Jie,YU Bo,JIN Xing-zao,ZHOU Xiao-jun

DOI: https://doi.org/10.3969/j.issn.1001-7399.2012.04.014

2012-01-01

Abstract:Purpose To investigate the clinicopathological characteristics,diagnosis and differential diagnosis of epithelioid hemangioendothelioma(EHE) derived from bone.Methods Four cases of EHE in bone were retrospectively reviewed on the clinical data,histological and immunohistochemical features,the follow-up,and the related literature.Results Cases studied consisted of 2 males and 2 females,with median age 24,and the anatomic locations included the right scapular bone,L4 vertebra,left distal tibia,and left foot.The main clinical and radiographic manifestations were ache and lytic lesions,respectively.Histologically,EHE was comprised of the epithelioid cells arranged in nets,cords and strands,usually,with the significant appearance of cytoplasmic vacuoles and the surrounding hyaline and myxoid stroma.Immunohistochemically,tumor cells were positive for CD31,CD34,α-SMA,and partly positive for CKpan(25%) and negative for EMA,in addition to the low expression of Ki-67.Conclusion EHE derived from bone is a rare and low aggressive tumor.A correct diagnosis needs the comprehensive evaluation including the relevant clinical pathology characteristics and immunohistochemistry,and the exclusion of metastatic carcinoma of bone,hemangioma,and epithelioid angiosarcoma.
Epithelioid hemangioendothelioma—its history, clinical features, molecular biology and current therapy

Kenji Tsuchihashi,Eishi Baba

DOI: https://doi.org/10.1093/jjco/hyae037

IF: 2.925

2024-03-30

Japanese Journal of Clinical Oncology

Abstract:Abstract Epithelioid hemangioendothelioma (EHE) is a remarkably rare tumor arising from endothelial cells that is classified as a vascular tumor in the WHO classification. The tumor is predominantly characterized by the presence of fusion genes, such as WWTR1-CAMTA1 or YAP1-TFE3, with a minority of cases exhibiting other rare fusion genes. EHE exhibits a broad age of onset, typically presenting at ~50 years, but it is not uncommon in pediatric populations. It manifests in a variety of organs, including the liver, lung, soft tissue and bone. Initial multiple-organ involvement is also observed. The tumor’s biological behavior and prognosis vary substantially based on the primary site of manifestation. From a therapeutic perspective, initial active surveillance might be considered in selected cases, although surgical intervention remains the mainstay of treatment, especially for localized single-organ involvement. Chemotherapy is administered to patients with progressive unresectable tumors. Recent advances in the biological analysis of EHE fusion genes have elucidated their diverse functions. Additionally, next-generation sequencing has facilitated the identification of other mutations beyond the fusion genes. These continuous efforts to understand the biology of the fusion genes themselves and/or the dysregulated signaling by fusion genes are expected to lead to the development of novel therapeutic strategies for EHE. This article aims to provide a comprehensive review of EHE, encompassing its historical context, clinical manifestations, molecular biology and the current state of treatment.

oncology
[Pulmonary epithelioid hemangioendothelioma].

S. Bugrov,S. Skryabin,L. Novikova,I. Dvorakovskaya,B. Ariel

DOI: https://doi.org/10.17116/patol20228402129

Arkhiv patologii

Abstract:The article describes the clinical, radiological and pathological features of epithelioid hemangioendothelioma (EHE) in 27 adult patients, mainly female. In all cases, with the exception of one, there was a benign course of the disease over many years with a tendency to stabilize growth, the morphological sign of which was the development of widespread sclerotic changes. With the help of immunohistochemical method, the endothelial nature of EHE cells and its relatively low proliferative potential were confirmed. Clinical and morphological features of EHE raise the question of the essence of proliferation of endothelial cells with the formation of tumor-like nodes. There is every reason to consider EHE as a pseudotumor of the type of nodose hyperplasia in the nosological group of dyshormonal hyperplasia, similar to benign leiomyoma of the uterus with lung damage, as we have previously proposed.

Medicine
Imiquimod contact pemphigus: a comment.

E. Ruocco,A. Baroni,L. Rossiello,V. Ruocco

DOI: https://doi.org/10.1016/J.EJOGRB.2004.01.027

2004-08-10

Abstract:
Rare Manifestation Of Epithelioid Hemangioendothelioma In Childhood.

Vívian Palata VIOLA,Catielma Nascimento SANTOS,Victor Tieghi NETO,Fabio Luiz CORACIN,Ricardo Ribeiro GAMA,Paulo Sérgio da Silva SANTOS

DOI: https://doi.org/10.1016/j.oooo.2023.12.096

2024-06-07

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Abstract:An 11-year-old female child, with complaint of a lesion on her gums. On clinical examination, a nodular, ulcerated, granulomatous, erythematous lesion was detected in the region of the right upper alveolar ridge, with slow growth, of approximately 3 years, with diffuse bleeding during feeding and no other associated symptoms. An incisional biopsy of the lesion was conducted, and its microscopic morphology showed a fragment of mucosa with a lamina propria consisting of dense connective tissue, with proliferation of epithelioid cells, with atypia and cellular pleomorphism in the midst of fibromyxoid stroma.

dentistry, oral surgery & medicine
Epithelioid hemangioma in the oral mucosa: a clinicopathological study of seven cases and review of the literature

Zhi-Jun Sun,Lu Zhang,Wen-Feng Zhang,Moh'd Jamal Alsharif,Xin-Ming Chen,Yi-Fang Zhao

DOI: https://doi.org/10.1016/j.oraloncology.2005.07.012

Abstract:To investigate the clinicopathological characteristics and biologic behavior of epithelioid hemangioma in oral mucosa, the clinical features and pathological findings of seven cases of epithelioid hemangioma were reviewed, and all sections were examined by immunohistochemistry. There were 4 males and 3 females ranged from 8 to 65 years (mean 39.7 years). Sites of origin included the tongue (n = 4), lips (n = 2), and palates (n = 1). Five lesions presented as a solitary mass. Three patients had history of minimal trauma. Histopathologically, well-formed but often immature vessels lined by plump epitholid endothelial cells with prominent inflammatory components were observed. Immunohistochemical staining revealed that tumour cells were positive for Vimentin, FVIIIRAg and CD34. All the cases were negative to S-100 protein and EMA. One case recurred after surgical excision, while none of them metastasized. Epithelioid hemangioma is a benign vascular anomaly, and has close relationship with local trauma. The differential diagnosis is usually based upon histopathological findings.
Uncommon vascular tumor of the ovary. Primary ovarian epithelioid hemangioendothelioma or vascular sarcomatous transformation in ovarian germ cell tumor?

Carmen Illueca,Isidro Machado,Ana García,Amparo Covisa,Javier Morales,Julia Cruz,Victor Traves,Sergio Almenar

DOI: https://doi.org/10.1007/s00404-011-2036-1

2011-08-07

Archives of Gynecology and Obstetrics

Abstract:Epithelioid hemangioendothelioma (EHE) is an unusual vascular tumor, which usually occurs in the soft tissue, liver, breast, lung and bone. We submit a case of EHE, a tumor never before reported in the ovary. A 20-year-old woman was admitted with a medical history of unilateral ovarian tumor. The right ovary was totally removed and histologically, the tumor was composed of epithelioid cells with eosinophilic cytoplasm and prominent intracytoplasmic vacuoles associated with myxohyaline matrix. No morphologic evidence of germ cell tumor was observed. Immunohistochemically, the tumor cells were positive for CD31 and CD34. However, all germ cell tumor markers were negative. The final diagnosis was EHE of the ovarian gland and sarcomatous transformation in ovarian germ cell tumor was excluded after extensive histopathological and immunohistochemical study. EHE is an uncommon vascular tumor, which is rarely seen in female genital tract and this is the first report of EHE in ovarian gland. Final diagnosis depends on histopathological and immunohistochemical features.

obstetrics & gynecology
Clinical and radiologic study in intracranial epithelioid haemangioendothelioma and a literature review

ZHANG Jun,LIANG Zong-hui,GENG Dao-ying,ZHU Li,LI Ke

DOI: https://doi.org/10.3969/j.issn.1007-3639.2009.07.010

2009-01-01

Abstract:Background and purpose:Primary intracranial epithelioid haemangioendothelioma (EH) was rare. This study was to discuss the clinical pathological features, radiographic findings, treatment and prognosis of primary intracranial EH combined with literature review. Methods:We reviewed a case of EH reported from our hospital, and comprehensively analyzed the related literature. Results:Based on our report and review of the literature, EH is rare and with borderline or uncertain behavior. The original tumors demonstrated specific image features. The tumor usually appeared as a small nest or cords composed of eosinophilic epithlioid or spindled cells. Immunohistochemical assay were positive for endothelial markers CD31, CD34 and FⅧ. EH may be treated with complete surgical resection whenever possible and is sensitive to radiation. The EH has a favorable prognosis. Conclusion:EH has variable malignant potential, and should be differentiated from meningioma. Total resection and close follow-up is recommended. Additional radiotherapy is advised for residual tumors.

Analysis of a SHA-256 Variant

Epithelioid hemangioendothelioma of the parotid gland: A case report in an unusual location with a review of the literature

Epithelioid Hemangioendothelioma as a Dangerous, Easy to Miss, and Nearly Impossible to Clinically Diagnose Condition: Case Report

Primary Intranodal Epithelioid Haemangioendothelioma in the Submandibular Region: A Case Report

A case report of parotid gland epithelioid hemangioendothelioma

An extremely rare case of pulmonary epithelioid hemangioendothelioma

Primary Malignant Myoepithelioma of the Left Maxillary Sinus: a Case Report.

Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment

Rapidly Progressive and Debilitating Epithelioid Hemangioendothelioma: An Atypical Presentation of a Rare Malignant Cutaneous Vascular Neoplasm

Vulvar epithelioid hemangioendothelioma

Diaphragm epithelioid hemangioendothelioma: a rare case report

Imaging findings in epithelioid hemangioendothelioma

Epithelioid hemangioendothelioma: an overview and update on a rare vascular tumor

Epithelioid Hemangioendothelioma of Bone: a Study of 4 Cases and Review of Literature

Epithelioid hemangioendothelioma—its history, clinical features, molecular biology and current therapy

[Pulmonary epithelioid hemangioendothelioma].

Imiquimod contact pemphigus: a comment.

Rare Manifestation Of Epithelioid Hemangioendothelioma In Childhood.

Epithelioid hemangioma in the oral mucosa: a clinicopathological study of seven cases and review of the literature

Uncommon vascular tumor of the ovary. Primary ovarian epithelioid hemangioendothelioma or vascular sarcomatous transformation in ovarian germ cell tumor?

Clinical and radiologic study in intracranial epithelioid haemangioendothelioma and a literature review